Friday, June 18, 2010

Tenormin




In some countries, this medicine may only be approved for veterinary use.


In the US, Tenormin (atenolol systemic) is a member of the drug class cardioselective beta blockers and is used to treat Alcohol Withdrawal, Angina, Angina Pectoris Prophylaxis, Anxiety, Esophageal Variceal Hemorrhage Prophylaxis, Heart Attack, High Blood Pressure, Migraine Prevention, Mitral Valve Prolapse, Supraventricular Tachycardia and Ventricular Tachycardia.

US matches:

  • Tenormin

  • Tenormin Tablets

  • Tenormin Intravenous

  • Tenormin Injection

UK matches:

  • Tenormin 25mg Tablets
  • Tenormin 100mg Tablets
  • Tenormin Injection 0.5mg/ml
  • Tenormin LS 50mg Tablets
  • Tenormin Syrup
  • Tenormin 100mg Tablets (SPC)

Ingredient matches for Tenormin



Atenolol

Atenolol is reported as an ingredient of Tenormin in the following countries:


  • Australia

  • Austria

  • Bahrain

  • Belgium

  • Bulgaria

  • Canada

  • Colombia

  • Costa Rica

  • Croatia (Hrvatska)

  • Cyprus

  • Czech Republic

  • Denmark

  • Dominican Republic

  • Ecuador

  • El Salvador

  • Ethiopia

  • Georgia

  • Germany

  • Ghana

  • Greece

  • Guatemala

  • Guyana

  • Honduras

  • Hong Kong

  • India

  • Indonesia

  • Iraq

  • Ireland

  • Italy

  • Japan

  • Kenya

  • Kuwait

  • Lebanon

  • Libya

  • Luxembourg

  • Malawi

  • Malaysia

  • Malta

  • Mexico

  • Mozambique

  • Nicaragua

  • Nigeria

  • Norway

  • Oman

  • Panama

  • Peru

  • Philippines

  • Portugal

  • Qatar

  • Saudi Arabia

  • Singapore

  • Slovenia

  • South Africa

  • Spain

  • Sri Lanka

  • Sudan

  • Sweden

  • Switzerland

  • Taiwan

  • Tanzania

  • Thailand

  • Uganda

  • United Arab Emirates

  • United Kingdom

  • United States

  • Venezuela

  • Vietnam

  • Yemen

  • Zambia

  • Zimbabwe

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment